Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.4K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K
Design Consideration01:22

Design Consideration

557
Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
557
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

399
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
399
Tensile Strength Considerations of Concrete01:16

Tensile Strength Considerations of Concrete

532
Considering the tensile strength of concrete involves recognizing that the theoretical strength of cement paste can be up to a thousand times higher than what is observed in practical applications. This significant discrepancy is largely attributed to the presence of microscopic cracks within the concrete. These cracks tend to amplify stress at their tips when a load is applied, a phenomenon explained by Griffith's theory of brittle fracture.
The dimensions and shape of a concrete specimen...
532

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and pathologic response of neoadjuvant pulsed electric field ablation and systemic therapy in early-stage resectable lung cancer: case series.

Journal of thoracic disease·2026
Same author

Reply to: "Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743" and "Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743".

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.

JTO clinical and research reports·2026
Same author

Identification of tumor-associated antigens with multi-cancer therapeutic potential.

Frontiers in immunology·2026
Same author

Amivantamab induces immune-mediated cytotoxicity in mesothelioma via EGFR and MET engagement.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.

Circulation·2026

Related Experiment Video

Updated: Jan 22, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.

Ming-Sound Tsao1, Michele Carbone2, Francoise Galateau-Salle3

  • 1Department of Pathology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|July 2, 2019
PubMed
Summary

Accurate mesothelioma diagnosis is vital for patient care. This consensus statement establishes standard pathology guidelines for National Cancer Institute (NCI)-sponsored clinical trials, improving diagnostic consistency for this rare cancer.

Keywords:
Clinical trialsCorrelativesMesotheliomaPathologic classificationPathology

More Related Videos

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.9K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.3K

Related Experiment Videos

Last Updated: Jan 22, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.9K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.3K

Area of Science:

  • Oncology
  • Pathology

Background:

  • Accurate mesothelioma diagnosis is crucial for effective clinical management.
  • Diagnostic challenges include reactive mesothelial cells, histopathological heterogeneity, and metastatic malignancies.
  • Molecular profiling advancements necessitate standardized pathology guidelines for clinical trials.

Purpose of the Study:

  • To develop consensus-based standard pathology guidelines for National Cancer Institute (NCI)-sponsored mesothelioma clinical trials.
  • To address diagnostic complexities and ensure consistency in mesothelioma pathology.
  • To facilitate translational research and biobanking for future mesothelioma studies.

Main Methods:

  • Convening of the NCI-Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting in March 2017.
  • Development of consensus recommendations through expert discussion and review.
  • Focus on specimen handling, pathologic classification, diagnosis, biobanking, and correlative studies.

Main Results:

  • Establishment of a consensus statement on standard pathology guidelines for mesothelioma.
  • Recommendations cover critical aspects from specimen handling to tissue correlative studies.
  • Guidelines aim to standardize pathology for NCI-sponsored clinical trials.

Conclusions:

  • Standardized pathology guidelines are essential for accurate mesothelioma diagnosis and clinical trial integrity.
  • The consensus statement provides a framework for consistent pathologic assessment.
  • Implementation of these guidelines will support advancements in mesothelioma research and treatment.